Middle East & Africa Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

Coverage: By Product (Device and Accessories), Device For Product (Desktop and Portable), Accessories For Product (Filters, Nose Clip, Support Arms, and Other Accessories), Application (Asthma, COPD, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End users)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Published
  • Report Code : TIPRE00043874
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : July 27, 2026
Middle East & Africa Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Report Date: July 27, 2026   |   Report Code: TIPRE00043874 Email: sales@theinsightpartners.com

2025 Market Size

US$

Base year value

2034 Forecast

US$

Projected by 2034

CAGR 2026-2034

4.4 %

Growth rate

Addressable Market

US$ 26,318.04 THOUSAND

(2026-2034)

The Middle East and Africa Forced Oscillometry Market size is expected to reach US$ 3,414.4 Thousand by 2034 from US$ 2,343.3 Thousand in 2025. The market is estimated to record a CAGR of 4.4% from 2026 to 2034.

Executive Summary and Middle East and Africa Forced Oscillometry Market Analysis:

The Middle East & Africa forced oscillometry market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The growth of the market is driven by rising respiratory disease prevalence, expanding healthcare infrastructure, and increasing awareness of early lung function testing. Countries such as Saudi Arabia, the UAE, and South Africa are investing in modern diagnostic technologies to address the growing burden of asthma, chronic obstructive pulmonary disease (COPD), and post-COVID respiratory complications. Urbanization, air pollution, and high smoking rates have increased demand for accurate, noninvasive pulmonary assessment tools. Forced oscillometry systems are gaining popularity as they require minimal patient effort, making them suitable for pediatric and elderly populations. Additionally, government-led healthcare reforms, expansion of private hospitals, and improved access to specialty clinics are accelerating adoption. International medical device manufacturers are also entering the region through partnerships and distribution agreements, enhancing product availability. Increasing training programs for pulmonologists and respiratory therapists support market penetration and long-term growth across MEA healthcare systems.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Middle East & Africa Forced Oscillometry Market: Strategic Insights

middle-east-and-africa-forced-oscillometry-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East and Africa Forced Oscillometry Market Segmentation Analysis:

  • By Product, the Middle East and Africa Forced Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
  • By Device for Product, the Middle East and Africa Forced Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
  • By Accessories For Product, the Middle East and Africa Forced Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
  • By Application, the Middle East and Africa Forced Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
  • By End User, the Middle East and Africa Forced Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Middle East & Africa Forced Oscillometry Market Report Scope

Report Attribute Details
Market size in 2025 US$ 2,343.3 Thousand
Market Size by 2034 US$ 3,414.4 Thousand
CAGR (2026 - 2034) 4.4%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Device
  • Accessories
By Device For Product
  • Desktop
  • Portable
By Accessories For Product
  • Filters
  • Nose Clip
  • Support Arms
  • Other Accessories
By Application
  • Asthma
  • COPD
  • Other Applications
Regions and Countries Covered Middle East and Africa
  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • COSMED Srl
  • Chest MI Inc
  • Morgan Scientific Inc
  • THORASYS Thoracic Medical Systems Inc.
  • Jaeger Medical GmbH
  • IngMar Medical
  • GANSHORN Medizin Electronic GmbH
  • Lothar Medical GmbH
  • Cognita Labs, LLC
  • RESTECH srl

Middle East & Africa Forced Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Forced Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

middle-east-and-africa-forced-oscillometry-market-cagr

Middle East and Africa Forced Oscillometry Market Outlook

Growing clinical emphasis on small airway dysfunction (SAD) detection is accelerating the adoption of forced oscillometry, as recent guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD 2023) and the European Respiratory Society underscore its superior sensitivity for identifying peripheral airway changes that conventional spirometry frequently overlooks. Oscillometry measures key parameters during quiet tidal breathing—such as the difference in resistance between 5 Hz and 20 Hz (R5–R20), low-frequency reactance (X5), and the area under the reactance curve (AX)—revealing heterogeneous narrowing, airway closure, and ventilation inhomogeneity in the small airways. This capability is particularly valuable in asthma-COPD overlap syndrome, where patients often show persistent symptoms despite near-normal spirometry, and in early-stage disease management for at-risk individuals (e.g., tobacco-exposed adults with preserved airflow). According to research published by the National Institutes of Health (NIH) in 2024, ~16.5% of symptomatic patients exhibit abnormal oscillometry despite having normal spirometry results. This sensitivity is vital for early COPD detection. Clinicians routinely incorporate oscillometry to more accurately phenotype patients, monitor treatment responses to therapies targeting peripheral airways (such as extrafine inhaled formulations), and predict exacerbation risk. Additionally, the WHO reported that COPD affected 391 million people globally in 2022. To address this, clinical guidelines in 2024 have recommended oscillometry as it measures peripheral airway resistance during normal tidal breathing. Product developments, such as the Tremoflo C-100 Airwave Oscillometry System, are designed to target small airways, providing a 30-second assessment that helps clinicians intervene before irreversible lung damage occurs. Examples include its use in post-COVID follow-up to detect lingering small-airway impairment, in preschool wheezing to differentiate transient from persistent asthma, and in COPD cohorts to stratify severity even within the same GOLD stage. As forced oscillometry adoption grows, it promises to refine diagnostic protocols in clinical trials and practice, fostering better outcomes in respiratory care.

By providing effort-independent, highly repeatable data, oscillometry is shifting clinical practice toward earlier intervention, better disease control, and reduced reliance on symptom scores alone, improving long-term outcomes in both obstructive and restrictive respiratory disorders.

Middle East and Africa Forced Oscillometry Market Country Insights

By country, the Middle East and Africa Forced Oscillometry Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. South Africa held the largest share in 2025.

South Africa faces a high burden of respiratory conditions such as asthma and COPD, where forced oscillometry offers a noninvasive method to evaluate lung mechanics, especially in vulnerable groups such as children and those in high-pollution areas. The country remains among those in Africa with the highest rates of childhood asthma. According to the article "Rising asthma rates in sub-Saharan Africa linked to urbanization and lack of care," published in October 2024, data from the International Study of Asthma and Allergies in Childhood (ISAAC) show that two-thirds of adolescents experienced severe asthma symptoms, while 80% had never been diagnosed. Meanwhile, the Burden of Obstructive Lung Disease (BOLD) study, which assessed global COPD prevalence, reported that 19% of South Africans are affected. The burden of COPD continues to grow due to persistent smoking and an aging population. Additionally, a 2023 cross-sectional study by the Global Asthma Network in KwaZulu-Natal reported a 13.7% prevalence of current wheeze among adolescents aged 13-14, indicating substantial underdiagnosis and a high symptom burden. Oscillometry, including forced oscillometry, allows tidal breathing assessments without forced maneuvers, making it particularly effective in detecting small airways dysfunction, a common early feature of COPD, asthma, and post-TB lung damage in South Africa. Compared to traditional spirometry, which is effort-dependent, oscillometry is especially suitable for pediatric, elderly, and comorbid patients. According to the European Respiratory Society's 2020 technical standards, its growing clinical use is attributed to its superior sensitivity to peripheral airway changes.

Middle East and Africa Forced Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, IngMar Medical, GANSHORN Medizin Electronic GmbH, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East and Africa Forced Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA